Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma

NCT02914405 · clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
44
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital Southampton NHS Foundation Trust

Collaborators